Do Patients with Second Primary Colorectal Cancer Hold the Similar Prognosis and Therapeutic Benefits as Those with Initial Primary Colorectal Cancer?

BioMed Research International
Quan ChenZhenning Wang

Abstract

The objective is to compare the differences on prognosis and the therapeutic benefits between initial and second primary colorectal cancer (pCRC). A dataset containing 377,271 initial pCRC cases and 18,617 second pCRC cases from the National Cancer Institute's Surveillance, Epidemiology, and End Results (SEER) 1988-2015 was evaluated. Survival comparisons were made using the log-rank test. Cox proportional hazards models were used to assess the survival benefits. The cancer-specific survival rate of patients with initial pCRC was significantly higher than that of patients with second pCRC (5-years survival rate: 64.85% vs. 60.22%, P<0.001). The Chi-square of stratified log rank for age at diagnosis was lower than that for primary site, pTNM stage, sex, race, histology, and grade (Chi-square=86.73). There were almost no differences on therapeutic benefits between patients with initial and second pCRC except that treatments with chemotherapy were significantly associated with longer survival rate compared with treatments without chemotherapy among stage III surgical initial and second primary left-sided colon cancers patients (HR=0.764 vs. 0.581; P for interaction =0.008). Patients with second pCRC have worse prognosis than those...Continue Reading

References

Mar 16, 1995·International Journal of Cancer. Journal International Du Cancer·G RennertA I Neugut
Aug 19, 2000·Diseases of the Colon and Rectum·H S Chen, S M Sheen-Chen
Jan 6, 2001·Arquivos De Gastroenterologia·M de S Cury, N M Forones
Jul 9, 2004·World Journal of Gastroenterology : WJG·Hong-Zhi WangJin Gu
Jul 15, 2005·World Journal of Gastroenterology : WJG·Hui-Yun ChengShou-Chuan Shih
Jul 21, 2005·European Journal of Cancer Prevention : the Official Journal of the European Cancer Prevention Organisation (ECP)·UNKNOWN Working Group Report
Jul 23, 2009·Annals of Oncology : Official Journal of the European Society for Medical Oncology·C L RinglandR L Ward
Jun 1, 2008·Cancer Research and Treatment : Official Journal of Korean Cancer Association·Joo Won YoonSung Uhn Baek
May 27, 2010·International Journal of Cancer. Journal International Du Cancer·Lifang LiuIsabelle Soerjomataram
Aug 29, 2012·Acta chirurgica Iugoslavica·Philipp HildebrandRalf Czymek
Mar 27, 2013·ANZ Journal of Surgery·Susie BaePeter Gibbs
Nov 15, 2013·Lancet·Hermann BrennerChristian Peter Pox
Mar 26, 2014·Journal of Cancer Research and Clinical Oncology·Julie Smith-GagenJonathan Tay
Jun 4, 2014·CA: a Cancer Journal for Clinicians·Carol E DeSantisAhmedin Jemal
Jun 16, 2015·World Journal of Gastroenterology : WJG·Hong ShenYing Yuan
Jan 9, 2016·CA: a Cancer Journal for Clinicians·Rebecca L SiegelAhmedin Jemal
Mar 2, 2017·CA: a Cancer Journal for Clinicians·Rebecca L SiegelAhmedin Jemal
Jun 24, 2017·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Summer S HanHeather A Wakelee

❮ Previous
Next ❯

Citations

Jun 27, 2019·Journal of Cellular Physiology·Behzad MansooriBehzad Baradaran

❮ Previous
Next ❯

Software Mentioned

SEER
STATA MP
SPSS Statistics

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

© 2022 Meta ULC. All rights reserved